AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now?

Core Insights - Axalta Coating Systems (AXTA) and Novozymes A/S (NVZMY) are both attractive options for value investors, currently holding a Zacks Rank of 2 (Buy) indicating a positive earnings outlook [1][3] Valuation Metrics - AXTA has a forward P/E ratio of 17.52, while NVZMY has a significantly higher forward P/E of 39.57 [2] - AXTA's PEG ratio is 0.85, suggesting it is undervalued relative to its expected EPS growth, whereas NVZMY's PEG ratio is 4.06 [2] - AXTA's P/B ratio stands at 4.37, compared to NVZMY's P/B ratio of 16.18, indicating a more favorable valuation for AXTA [2] Value Grades - Based on the analysis of various valuation metrics, AXTA receives a Value grade of B, while NVZMY is assigned a Value grade of F, highlighting AXTA as the superior value option at this time [3]